Skip to content
stockresearch.app
ZBH/History

Zimmer Biomet (ZBH) valuation history

Below its usual range

As of

ZBH's EV/EBITDA of 11.0x is lower than 83% of its available weekly readings from the last five years.

EV/EBITDA weekly history8.6×13.5×18.4×23.2×Shading: 5-year middle halfMedian 13.9×11.0×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

ZBH year-end valuation history
Reading dateEV/EBITDA5-year rank
10.3×1%
12.2×1%
16.8×25%
17.9×43%
16.5×18%
44.3×98%
37.1×99%
16.0×14%
16.4×34%
16.3×Short history

Loading related research…

About this history

What is ZBH's current EV/EBITDA?
ZBH's EV/EBITDA of 11.0x is lower than 83% of its available weekly readings from the last five years.
What is ZBH's five-year median EV/EBITDA?
The median, or middle weekly reading, is 13.9× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology